Page 1 of Clinical Trials for unresectable neuroendocrine tumor, 160 Total Matches
- 1TerminatedLast Updated: November 9, 2011Condition(s): Neuroendocrine Tumors; Carcinoid Tumors; Adrenal Gland Tumors; Neuroblastoma; Pancreatic Neuroendocrine Tumors; Multiple Endocrine Neoplasia
- 2Active, not recruitingPhase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine TumorsLast Updated: February 8, 2010Condition(s): Neuroendocrine Tumors
- 3CompletedLast Updated: April 27, 2009Condition(s): Neuroendocrine Tumor
- 4CompletedLast Updated: July 18, 2008Condition(s): Neuroendocrine Tumors
- 5RecruitingLast Updated: January 10, 2012Condition(s): Neuroendocrine Tumor
- 6RecruitingLast Updated: February 9, 2012Condition(s): Neuroendocrine Tumors
- 7RecruitingLast Updated: July 15, 2009Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Tumor
- 8Not yet recruitingLast Updated: February 1, 2012Condition(s): Gastrinoma; Glucagonoma; Insulinoma; Pancreatic Polypeptide Tumor; Recurrent Islet Cell Carcinoma; Recurrent Pancreatic Cancer; Somatostatinoma; Stage III Pancreatic Cancer; Stage IV Pancreatic Cancer
- 9Not yet recruitingLast Updated: May 22, 2012Condition(s): Well-differentiated Pancreatic Neuroendocrine Tumor
- 10RecruitingDoxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine TumorsLast Updated: February 26, 2009Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Metastatic Cancer
- 11RecruitingLast Updated: March 8, 2012Condition(s): Neuroendocrine Tumors; Carcinoid Tumors
- 12CompletedLast Updated: December 17, 2007Condition(s): Neuroendocrine Carcinoma
- 13CompletedLast Updated: August 30, 2011Condition(s): Neuroendocrine Carcinoma
- 14CompletedLast Updated: March 21, 2012Condition(s): Colorectal Cancer; Islet Cell Tumor; Liver Cancer; Metastatic Cancer; Neuroendocrine Carcinoma
- 15CompletedLast Updated: March 22, 2011Condition(s): Neuroendocrine Carcinoma; Islet Cell Carcinoma
- 16RecruitingLast Updated: October 16, 2010Condition(s): Breast Cancer; Colorectal Cancer; Gastric Cancer; Liver Cancer; Melanoma (Skin); Metastatic Cancer; Ovarian Cancer; Pancreatic Cancer
- 17CompletedLast Updated: May 13, 2011Condition(s): Gastrointestinal Cancer; Carcinoma, Neuroendocrine
- 18CompletedLast Updated: January 11, 2012Condition(s): Neuroendocrine Carcinoma of the Skin
- 19Active, not recruitingLast Updated: March 5, 2012Condition(s): Extensive Stage Small Cell Lung Cancer; Hereditary Paraganglioma; Male Breast Cancer; Malignant Paraganglioma; Metastatic Gastrointestinal Carcinoid Tumor; Metastatic Pheochromocytoma; Pancreatic Polypeptide Tumor; Recurrent Breast Cancer; Recurrent Cervical Cancer; Recurrent Endometrial Carcinoma; Recurrent Gastrointestinal Carcinoid Tumor; Recurrent Islet Cell Carcinoma; Recurrent Neuroendocrine Carcinoma of the Skin; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Pheochromocytoma; Recurrent Prostate Cancer; Recurrent Renal Cell Cancer; Recurrent Small Cell Lung Cancer; Recurrent Uterine Sarcoma; Regional Gastrointestinal Carcinoid Tumor; Regional Pheochromocytoma; Stage III Cervical Cancer; Stage III Endometrial Carcinoma; Stage III Neuroendocrine Carcinoma of the Skin; Stage III Ovarian Epithelial Cancer; Stage III Ovarian Germ Cell Tumor; Stage III Prostate Cancer; Stage III Renal Cell Cancer; Stage III Uterine Sarcoma; Stage IIIA Breast Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Breast Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer; Stage IV Endometrial Carcinoma; Stage IV Neuroendocrine Carcinoma of the Skin; Stage IV Non-small Cell Lung Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Stage IV Prostate Cancer; Stage IV Renal Cell Cancer; Stage IV Uterine Sarcoma; Stage IVA Cervical Cancer; Stage IVB Cervical Cancer; Thyroid Gland Medullary Carcinoma
- 20Active, not recruitingLast Updated: April 5, 2012Condition(s): Neoplasms; Melanoma; Unresectable Metastatic Cutaneous Melanoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=unresectable+neuroendocrine+tumor
